Yayınlar & Eserler

Yayın Ağı
Makaleler 104
Tümü (104)
SCI-E, SSCI, AHCI (95)
SCI-E, SSCI, AHCI, ESCI (95)
Scopus (96)
TRDizin (4)
Diğer Yayınlar (2)

1. Efficacy and tolerability of switching from coated to compressed colchicine preparations in patients with Behçet’s syndrome

Fidan S., ESATOĞLU S. N., ÖZGÜLER Y., UĞURLU S., SEYAHİ E., MELİKOĞLU M., et al.
Rheumatology , cilt.65, sa.2, 2026 (SCI-Expanded, Scopus) identifier identifier identifier

2. De novo manifestations during adalimumab treatment in Behçet's syndrome

ESATOĞLU S. N., SÖNMEZ Ö., UÇAR D., Kaymaz E., ÖZGÜLER Y., UĞURLU S., et al.
RHEUMATOLOGY , cilt.64, sa.4, ss.2034-2040, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

3. Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders

Sota J., Guerriero S., Lopalco G., TUFAN A., Ragab G., Almaglouth I., et al.
OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.33, sa.1, ss.48-55, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

4. Pulmonary artery involvement due to Behçet's syndrome and Hughes Stovin syndrome: a comparative study.

Ordu B., ASLAN M. Ç., ÖZGÜLER Y., Durmaz E. Ş., Melikoglu M., FRESKO İ., et al.
Clinical and experimental rheumatology , cilt.42, sa.10, ss.2021-2031, 2024 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

5. Behçet’s syndrome: one year in review 2024

Hatemi G., Seyahi E., Fresko İ., Talarico R., Uçar D., Hamuryudan V.
Clinical and Experimental Rheumatology , cilt.42, sa.10, ss.1999-2007, 2024 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

6. A giant tongue ulcer: don’t miss the treatable cause!

ERDOĞAN M. S., BİLGİÇ GAZİOĞLU S., FRESKO İ.
Clinical and Experimental Rheumatology , cilt.42, sa.4, ss.943-944, 2024 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

7. Mycophenolate mofetil may be an alternative for maintenance therapy of Behçet syndrome uveitis: a single-center retrospective analysis

UÇAR D., ESATOĞLU S. N., Cerme E., BATU OTO B., Hamuryudan V., SEYAHİ E., et al.
Rheumatology International , cilt.43, sa.11, ss.2099-2106, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

8. De Novo Manifestations During Adalimumab Treatment in Behcet Syndrome

ESATOĞLU S. N., SÖNMEZ Ö., UÇAR D., Kaymaz E., ÖZGÜLER Y., UĞURLU S., et al.
ARTHRITIS & RHEUMATOLOGY , ss.3070-3072, 2023 (SCI-Expanded, Scopus) identifier

9. Sistemik lupus eritematozusda plazma değişim tedavisi: Tek merkez retrospektif kohort çalışması

Özgüler Y., Ak T., Esatoğlu S. N., Elverdi T., Eşkazan A. E., Uğurlu S., et al.
Ulusal Romatoloji Dergisi , cilt.15, sa.2, ss.89-94, 2023 (TRDizin)

10. ANCA ile ilişkili vaskülitte plazma değişim tedavisi: Tek merkez retrospektif kohort çalışması

Özgüler Y., Ak T., Esatoğlu S. N., Elverdi T., Eşkazan A. E., Uğurlu S., et al.
Ulusal Romatoloji Dergisi , cilt.14, sa.3, ss.131-136, 2022 (Scopus, TRDizin) identifier identifier

11. Frequency of AA amyloidosis has decreased in Behcet's syndrome: a retrospective study with long-term follow-up and a systematic review Amyloidosis in Behcet's syndrome

Karatemiz G., ESATOĞLU S. N., Gurcan M., ÖZGÜLER Y., YURDAKUL S., HAMURYUDAN V., et al.
RHEUMATOLOGY , cilt.62, sa.1, ss.9-18, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

12. Outcome of Vascular Involvement of Behcet Syndrome Treated with Infliximab: A Retrospective Cohort Study

HATEMİ G., TÜKEK N. B., ESATOĞLU S. N., ÖZGÜLER Y., Taflan S. S., MELİKOĞLU M., et al.
ARTHRITIS & RHEUMATOLOGY , ss.3098-3099, 2022 (SCI-Expanded, Scopus) identifier

13. The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behcet's syndrome

Ozcifci G., Aydin T., Atli Z., BALKAN İ. İ., TABAK Ö. F., ÖZTAŞ M., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.42, sa.1, ss.101-113, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

14. Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study

Ortiz-Fernández L., Saruhan-Direskeneli G., Alibaz-Oner F., Kaymaz-Tahra S., Coit P., Kong X., et al.
American Journal of Human Genetics , cilt.108, sa.1, ss.84-99, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

15. Long term follow-up of Behçet's syndrome patients treated with cyclophosphamide.

Gurcan M., Esatoglu S. N., Hamuryudan V., Saygin D., Ugurlu S., Seyahi E., et al.
Rheumatology (Oxford, England) , cilt.59, sa.9, ss.2264-2271, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

16. One year in review 2020: Behçet's syndrome

Hatemi G., Seyahi E., Fresko İ., Talarico R., HAMURYUDAN V.
Clinical and experimental rheumatology , cilt.38, sa.5, ss.3-10, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

17. Trial of Apremilast for Oral Ulcers in Behcet's Syndrome

Hatemi G., Mahr A., Ishigatsubo Y., Song Y., Takeno M., Kim D., et al.
NEW ENGLAND JOURNAL OF MEDICINE , cilt.381, sa.20, ss.1918-1928, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

18. One year in review 2019: Behçet's syndrome

Hatemi G., Seyahi E., Fresko İ., Talarico R., Hamuryudan V.
Clinical and experimental rheumatology , cilt.37, sa.6, ss.3-17, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

19. Outcome of invasive procedures for venous thrombosis in Behçet's syndrome: case series and systematic literature review.

Dincses E., Esatoglu S. N., Fresko İ., MELİKOĞLU M., Seyahi E.
Clinical and experimental rheumatology , sa.6, ss.125-131, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

20. Disease Course of Behcet's Syndrome Patients Not Fulfilling International Study Group Criteria at Presentation

Esatoglu S. N., Bilgin S., Sulu C., Hamuryudan V., Kutlubay Z., MELİKOĞLU M., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded, Scopus) identifier

21. Biosimilar infliximab for Behcet's syndrome: a case series

Dincses E., Esatoglu S. N., Ozguler Y., Uygunoglu U., Hamuryudan V., Seyahi E., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.37, sa.6, ss.111-115, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

22. Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studies

Ayan G., Esatoglu S. N., Hatemi G., Ugurlu S., Seyahi E., Melikoglu M., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.38, sa.4, ss.607-622, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

23. One year in review 2018: Behçet’s syndrome

Hatemi G., Seyahi E., Fresko İ., TALARICO R., Hamuryudan V.
Clinical and Experimental Rheumatology , cilt.36, sa.6, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

24. Surgical Therapies in the Treatment of Pulmonary Artery Involvement in Behcet's Syndrome

Tuzun H., Guzelant G., Demirhan O., Oz B., Fresko I., Hamuryudan V., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded, Scopus) identifier

25. One year in review 2017: Behçet's syndrome

Hatemi G., Seyahi E., Fresko İ., Talarico R., Hamuryudan V.
Clinical and Experimental Rheumatology , cilt.35, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

26. One year in review 2016: Belicet's syndrome

Hatemi G., Seyahi E., Fresko İ., TALARICO R., Hamuryudan V.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

27. Associated Inflammatory Diseases in Takayasu's Arteritis: The Many Faces of a Disease

Esatoglu S. N., Celik A. M., UÇAR D., Celik A. F., UĞURLU S., HATEMİ G., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus) identifier

28. Behcet's syndrome: a critical digest of the 2014-2015 literature

Hatemi G., Seyahi E., Fresko İ., Talarico R., Hamuryudan V.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.33, sa.6, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

29. Can We Differentiate Takayasu's Arteritis from Atherosclerosis Using Carotid Artery Doppler Usg?

UĞURLU S., KESKİN F. E., CETINKAYA F., MELİKOĞLU M., HAMURYUDAN V., FRESKO İ., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

30. Identification of susceptibility loci in IL6, RPS9/LILRB3, and an intergenic locus on chromosome 21q22 in takayasu arteritis in a genome-wide association study

RENAUER P. A., Saruhan-Direskeneli G., COIT P., ADLER A., AKSU K., KESER G., et al.
Arthritis and Rheumatology , cilt.67, sa.5, ss.1361-1368, 2015 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

31. Behcet's syndrome: a critical digest of the 2013-2014 literature

Hatemi G., Seyahi E., Fresko İ., Talarico R., Hamuryudan V.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.4, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

32. Behcet's disease as a systemic disease

Mat M. C., Sevim A., Fresko I., Tuzun Y.
CLINICS IN DERMATOLOGY , cilt.32, sa.3, ss.435-442, 2014 (SCI-Expanded, Scopus) identifier identifier

33. Inadequate Description and Discussion of Enrolled Patient Characteristics and Potential Inter-Study Site Differences in Reports of Randomized Controlled Trials: A Systematic Survey in Six Rheumatology Journals

Yurdakul S., Mustafa B. N., Fresko I., Seyahi E., Yazici H.
ARTHRITIS & RHEUMATOLOGY , cilt.66, sa.5, ss.1395-1399, 2014 (SCI-Expanded, Scopus) identifier identifier identifier

34. Novel NLRP3/cryopyrin mutations and pro-inflammatory cytokine profiles in Behets syndrome patients

YÜKSEL Ş., Eren E., Hatemi G., Sahillioglu A. C., Gultekin Y., Demiroz D., et al.
INTERNATIONAL IMMUNOLOGY , cilt.26, sa.2, ss.71-81, 2014 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

35. Identification of multiple genetic susceptibility loci in Takayasu arteritis

Saruhan-Direskeneli G., HUGHES T., AKSU K., KESER G., COIT P., AYDIN S., et al.
American Journal of Human Genetics , cilt.93, sa.2, ss.298-305, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

36. PDCD1 polymorphisms are not associated with Takayasu's arteritis in Turkey

Direskeneli H., Tuna-Erdoǧan E., Gündüz F., Bandurska-Luque A., Alparslan B., Kebe M., et al.
Clinical and Experimental Rheumatology , cilt.30, 2012 (SCI-Expanded, Scopus) identifier identifier

37. Behcet's syndrome: a critical digest of the recent literature

Hatemi G., Seyahi E., Fresko İ., Hamuryudan V.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.30, sa.3, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

38. 15th International Congress on Behçet's Disease.

FRESKO İ.
Clinical and experimental rheumatology , cilt.30, 2012 (SCI-Expanded, Scopus) identifier identifier

39. Takayasu's arteritis is associated with HLA-B*52, but not with HLA-B*51, in Turkey

Sahin Z., Bicakcigil M., AKSU K., Kamali S., Akar S., ÖNEN F., et al.
ARTHRITIS RESEARCH & THERAPY , cilt.14, sa.1, 2012 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

40. Determination of oxidant stress in plasma of rheumatoid arthritis and primary osteoarthritis patients

TETİK Ş., Ahmad S., Alturfan A. A., Fresko I., Disbudak M., Sahin Y., et al.
INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS , cilt.47, sa.6, ss.353-358, 2010 (SCI-Expanded, Scopus) identifier identifier identifier

41. Differences in pain and fatigue perception among a group of rheumatoid arthritis patients in the United States and in Turkey who have similar disease activity and functional status

Celik S., Fresko İ., Sut N., Batumlu N. M., Yazici H., Yazici Y.
Clinical and Experimental Rheumatology , cilt.28, sa.6, ss.884-887, 2010 (SCI-Expanded, Scopus) identifier identifier identifier

42. A twin study in Behçet's syndrome

Masatlioglu S., SEYAHİ E., Tahir Turanlı E., FRESKO İ., Gogus F., Senates E., et al.
Clinical and Experimental Rheumatology , cilt.28, 2010 (SCI-Expanded, Scopus) identifier identifier identifier

43. CURRENT TRENDS IN THE MANAGEMENT OF BEHCET'S SYNDROME

Hatemi G., Hamuryudan V., Tascilar K., Yurdakul S., Fresko I., Melikoglu M., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.28, sa.4, 2010 (SCI-Expanded, Scopus) identifier

44. Endothelial Dysfunction and Atherosclerosis in Behcet's Syndrome

Seyahi E., Fresko I., Yazici H.
BEHCET'S SYNDROME , ss.135-148, 2010 (SCI-Expanded) identifier

45. Locomotor System Disease in Behcet's Syndrome

Yurdakul S., Hatemi G.
BEHCET'S SYNDROME , ss.149-163, 2010 (SCI-Expanded) identifier

46. Reply to letter by Priori et al commenting on whether Behcet's syndrome patients with acne and arthritis comprise a true subset

Hatemi G., Fresko I., Yurdakul S., Ozdogan H., Yazici H., Altiok E., et al.
ARTHRITIS AND RHEUMATISM , cilt.62, sa.1, ss.305-306, 2010 (SCI-Expanded, Scopus) identifier identifier identifier

47. Miscellaneous Manifestations of Behcet's Disease

Calamia K. T., Fresko I.
BEHCET'S SYNDROME , ss.189-204, 2010 (SCI-Expanded) identifier identifier

48. Takayasu's arteritis in Turkey - Clinical and angiographic features of 248 patients

Bicakcigil M., Aksu K., Kamali S., Ozbalkan Z., Ates A., Karadag O., et al.
Clinical and Experimental Rheumatology , cilt.27, 2009 (SCI-Expanded, Scopus) identifier identifier identifier

49. Efficacy and safety of TNF-alpha antagonists in the management of Behcet's syndrome - a systematic survey

Hatemi G., Hamuryudan V., Yurdakul S., Yazici H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.27, sa.5, ss.736, 2009 (SCI-Expanded, Scopus) identifier

50. Treatment strategies for Behcet's disease

Fresko I., Yazici H.
EXPERT OPINION ON PHARMACOTHERAPY , cilt.9, sa.18, ss.3211-3219, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

51. Atherosclerosis in Behcet's syndrome

Seyahi E., Ugurlu S., Cumali R., Balci H., Ozdemir O., Melikoglu M., et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.38, sa.1, ss.1-12, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

52. IL-6 receptor, IL-8 receptor and TNF-α238 (G/A) polymorphisms are not associated with Behçet's disease in patients of German or Turkish origin

Storz K., Loeffler J., Koch S., Vonthein R., Zouboulis C. C., Fresko İ., et al.
Clinical and Experimental Rheumatology , cilt.26, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

53. CAN THE EQ-5D BE USED AS A HEALTH RELATED QUALITY OF LIFE INSTRUMENT IN PATIENTS WITH BEHCET'S SYNDROME?

SÜT N., Fresko I., Celik S., Senocak M.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.26, sa.4, 2008 (SCI-Expanded, Scopus) identifier

54. Increased enthesopathy among Behcet's syndrome patients with acne and arthritis

Hatemi G., Fresko I., Tascilar K., Yazici H.
ARTHRITIS AND RHEUMATISM , cilt.58, sa.5, ss.1539-1545, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

55. PTPN22 gene polymorphism in Takayasu's arteritis

Sahin N., Aksu K., Kamali S., Bicakcigil M., Oezbalkan Z., Fresko İ., et al.
Rheumatology , cilt.47, sa.5, ss.634-635, 2008 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

56. The role of HLA-DRB1 shared epitope alleles in predicting short-term response to leflunomide in rheumatoid arthritis

Saruhan-Direskeneli G., Inanc M., Fresko İ., Akkoc N., Dalkilic E., Erken E., et al.
Rheumatology , cilt.46, sa.12, ss.1842-1844, 2007 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

57. Increased serum sialic acid levels in primary osteoarthritis and inactive rheumatoid arthritis

Alturfan A. A., Uslu E., Alturfan E. E., Hatemi G., Fresko İ., Kokoglu E.
Tohoku Journal of Experimental Medicine , cilt.213, sa.3, ss.241-248, 2007 (SCI-Expanded, Scopus) identifier identifier identifier

58. The health system for patients with rheumatic disease: A rheumatology service Sistema sanitario para los pacientes con enfermedades reumáticas: Un servicio de reumatología

Olivé A., Olivé A., Monteagudo I., Wolf A., Leeb B., Graninger W., et al.
Seminarios de la Fundacion Espanola de Reumatologia , cilt.8, sa.3, ss.130-144, 2007 (Scopus) identifier identifier

59. Infliximab does not suppress the tuberculin skin test (purified protein derivative)

Hatemi G., Melikoglu M., Fresko I., Masatlioglu S., Tascilar K., Yazici H.
JOURNAL OF RHEUMATOLOGY , cilt.34, sa.3, ss.474-480, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

60. Behcet's syndrome: disease manifestations, management, and advances in treatment

Yazici H., Fresko I., Yurdakul S.
NATURE CLINICAL PRACTICE RHEUMATOLOGY , cilt.3, sa.3, ss.148-155, 2007 (SCI-Expanded, Scopus) identifier identifier identifier

61. Interleukin (IL)-12, IL-2, and IL-6 Gene Polymorphisms in Takayasu's Arteritis from Turkey

Saruhan-Direskeneli G., Bicakcigil M., Yilmaz V., Kamali S., Aksu K., Fresko İ., et al.
Human Immunology , cilt.67, sa.9, ss.735-740, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

62. Hair diameter in systemic lupus erythematosus

Seyahi E., Seyahi N., Fresko İ., Kuyumcu M., Yazici H.
Lupus , cilt.15, sa.5, ss.282-284, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

63. A double-blind trial of depot corticosteroids in Behcet's syndrome

Mat C., Yurdakul S., Uysal S., Gogus F., Ozyazgan Y., Uysal O., et al.
RHEUMATOLOGY , cilt.45, sa.3, ss.348-352, 2006 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

64. The management of Behçet's syndrome.

SEYAHİ E., FRESKO İ., MELİKOĞLU M., Yazici H.
Acta reumatológica portuguesa , cilt.31, sa.2, ss.125-131, 2006 (SCI-Expanded, Scopus) identifier identifier

65. Behçet's disease and other autoinflammatory conditions: What's in a name?

Yazici H., Fresko İ.
Clinical and Experimental Rheumatology , cilt.23, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

66. Oxidative burst response to monosodium urate crystals in patients with Behçet's syndrome

Gogus F., Fresko İ., Elbir Y., Eksioglu-Demiralp E., Direskeneli H.
Clinical and Experimental Rheumatology , cilt.23, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

67. The relationship between arthritis and human parvovirus B19 infection

Caliskan R., Masatlioglu S., Aslan M., Altun S., Saribas S., Ergin S., et al.
Rheumatology International , cilt.26, sa.1, ss.7-11, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

68. Fibrinolytic activity and d-dimer levels in Behcet's syndrome

Yurdakul S., Hekim N., Soysal T., Fresko I., Bavunoglu I., Ozbakir F., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.23, sa.4, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

69. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behcet's syndrome

Fresko İ., Ugurlu S., Ozbakir F., Celik A. F., Yurdakul S., Hamuryudan V., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.23, sa.4, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

70. Serum mannose-binding lectin levels are decreased in Behçet's disease and associated with disease severity

Inanc N., Mumcu G., Birtas E., Elbir Y., Yavuz S., Ergun T., et al.
Journal of Rheumatology , cilt.32, sa.2, ss.287-291, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

71. Effects of interferon-alpha treatment on serum IL-6, IL-8, TNF-alpha and soluble TNF-alpha receptors in Behcet's disease

Direskeneli H., Fresko İ., Hamuryudan V.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY , cilt.34, sa.1, ss.75-76, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

72. Short-term trial of etanercept in Behcet's disease: A double blind, placebo controlled study

Melikoglu M., Fresko I., Mat C., Ozyazgan Y., Gogus F., Yurdakul S., et al.
JOURNAL OF RHEUMATOLOGY , cilt.32, sa.1, ss.98-105, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

73. Pulmonary artery aneurysms in Behcet syndrome

Hamuryudan V., Er T., Seyahi E., Akman C., Tuzun H., Fresko İ., et al.
AMERICAN JOURNAL OF MEDICINE , cilt.117, sa.11, ss.867-870, 2004 (SCI-Expanded, Scopus) identifier identifier identifier

74. Oral health is impaired in Behçet's disease and is associated with disease severity

Mumcu G., Ergun T., Inanc N., Fresko İ., Atalay T., Hayran O., et al.
Rheumatology , cilt.43, sa.8, ss.1028-1033, 2004 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

75. A New marker in Rheumatoid Arthritis-Autoimmunity Relation: Anti-Cyclic citrullinated peptide antibody.

ALTUN S., ÇALIŞKAN R., ONUR Y., ASLAN M., SARIBAŞ S., ARTİNYAN E., et al.
Turkish Journal of Immunology , ss.21-26, 2004 (Scopus, TRDizin)

76. Infliximab and primary Sjögren's syndrome: Comment on the article by Mariette et al [3] (multiple letters)

Fresko İ., Seyahi E., Yurdakul S.
Arthritis and Rheumatism , cilt.50, sa.12, ss.4077, 2004 (SCI-Expanded, Scopus) identifier identifier identifier

77. Massive hematuria in rheumatoid arthritis: An unusual manifestation of reactive amyloidosis [2]

Altiparmak M. R., Pamuk O., Fresko İ.
Clinical and Experimental Rheumatology , cilt.21, sa.6, ss.799-800, 2003 (SCI-Expanded, Scopus) identifier identifier identifier

78. The long-term mortality and morbidity of Behcet syndrome - A 2-decade outcome survey of 387 patients followed at a dedicated center

Kural-Seyahi E., Fresko I., Seyahi N., Ozyazgan Y., Mat C., Hamuryudan V., et al.
MEDICINE , cilt.82, sa.1, ss.60-76, 2003 (SCI-Expanded, Scopus) identifier identifier identifier

79. Superoxide dismutase activity and glutathione system in erythrocytes of men with Behchet's disease

Dincer Y., Alademir Z., Hamuryudan V., Fresko İ., Akcay T.
Tohoku Journal of Experimental Medicine , cilt.198, sa.3, ss.191-195, 2002 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

80. Target organ associations in Turkish patients with Behçet's disease: A cross sectional study by exploratory factor analysis

Tunc R., Keyman E., Melikoglu M., Fresko İ., Yazici H.
Journal of Rheumatology , cilt.29, sa.11, ss.2393-2396, 2002 (SCI-Expanded, Scopus) identifier identifier identifier

81. Evaluation of patients for tuberculosis prior to treatment with anti-tumor necrosis factor-α biological agents: Consensus meeting report March 2, 2002 / İstanbul

Akkoç N., DİRESKENELİ R. H., Ertenli I., FRESKO İ., Gül A., HAMURYUDAN V., et al.
Marmara Medical Journal , cilt.15, sa.4, ss.273-276, 2002 (Scopus, TRDizin) Sürdürülebilir Kalkınma identifier

82. Highlights of the 10th International Congress on Behçet's disease

FRESKO İ.
Clinical and Experimental Rheumatology , cilt.20, 2002 (SCI-Expanded, Scopus) identifier identifier

83. Comparative analysis of the association of HLA-B*51 suballeles with Behçet's disease in patients of German and Turkish origin

Kotter I., Gunaydin I., Stubiger N., Yazici H., Fresko İ., Zouboulis C., et al.
Tissue Antigens , cilt.58, sa.3, ss.166-170, 2001 (SCI-Expanded, Scopus) identifier identifier identifier

84. Nailfold capillary abnormalities in patients with familial Mediterranean fever

Dinc A., Melikoglu M., Korkmaz C., Fresko İ., Ozdogan H., Yazici H.
Clinical and Experimental Rheumatology , cilt.19, 2001 (SCI-Expanded, Scopus) identifier identifier identifier

85. Absence of ANCA in Behcçet’s Syndrome with Large Vessel Involvement

Tunç U., ÖZBAKIR F., Çağlayan A., Altıparmak M., Yargan P., FRESKO İ., et al.
INTERNATIONAL JOURNAL OF ACAROLOGY , cilt.10, ss.260-262, 2001 (Scopus)

86. A reappraisal of amyloidosis in Behçet's syndrome.

Melikoglu M., Altiparmak M. R., Fresko I., Tunc R., Yurdakul S., Hamuryudan V., et al.
Rheumatology (Oxford, England) , cilt.40, sa.2, ss.212-5, 2001 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

87. Absence of ANCA in Behçet's syndrome with large vessel involvement

Tunc R., Ozbakir F., Caglayan A., ALTIPARMAK M. R., Yargan P., FRESKO İ., et al.
International Journal of Angiology , cilt.10, sa.4, ss.260-262, 2001 (Scopus) identifier

88. Intestinal permeability in Behcet's syndrome

Fresko İ., Hamuryudan V., Demir M., Hizli N., Sayman H. B., Melikoglu M., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.60, sa.1, ss.65-66, 2001 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

89. A survey of phenotype II in familial Mediterranean fever

Melikoglu M., Ozdogan H. A., Korkmaz C., Kasapcopur O., Arisoy N., Akkus S., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.59, sa.11, ss.910-913, 2000 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

90. The 20 year prognosis of Behcet's Syndrome.

Kurai E., SEYAHİ N., Ozyazgan Y., Mat C., Yurdakul S., HAMURYUDAN V., et al.
ARTHRITIS AND RHEUMATISM , cilt.43, sa.9, 2000 (SCI-Expanded) identifier

91. Behçet sendromunda antimikobakteriyal antikorlar

MERT A., ÖZTÜRK R., Sipahi S., FRESKO İ., Aslan M., HAMURYUDAN V., et al.
İnfeksiyon Dergisi(Turkish Journal of Infection) , cilt.13, sa.4, ss.527-529, 1999 (Hakemli Dergi)

92. A case of systemic sclerosis that developed under dexfenfluramine use [8]

Korkmaz C., Fresko İ., Yazici H.
Rheumatology , cilt.38, sa.4, ss.379-380, 1999 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

93. The management of Behcet's syndrome

Fresko İ., Yurdakul S., Hamuryudan V., Ozyazgan Y., Mat C., Tanverdi M., et al.
Annales de Medecine Interne , cilt.150, sa.7, ss.576-581, 1999 (SCI-Expanded, Scopus) identifier identifier identifier

94. A reappraisal of amyloidosis in Behcet's syndrome

ALKAN MELİKOĞLU M., ALTIPARMAK M. R., FRESKO İ., Yurdakul S., HAMURYUDAN V., Yazici H.
ARTHRITIS AND RHEUMATISM , cilt.42, sa.9, 1999 (SCI-Expanded) identifier

95. Evaluation of the Turkish translation of a disease activity form for Behcet's syndrome

Hamuryudan V., Fresko İ., Direskeneli H., Tenant M., Yurdakul S., Akoglu T., et al.
RHEUMATOLOGY , cilt.38, sa.8, ss.734-736, 1999 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

96. Extrapyramidal type rigidity in rheumatoid arthritis

Ertan S., Fresko İ., Apaydin H., Ozekmekci S., Yazici H.
Rheumatology , cilt.38, sa.7, ss.627-630, 1999 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

97. Behcet's disease in the Middle East

Saylan T., Mat C., Fresko İ., Melikoglu M.
Clinics in Dermatology , cilt.17, sa.2, ss.209-223, 1999 (SCI-Expanded, Scopus) identifier identifier identifier

98. Behcet's syndrome - The cerrahpasa experience

Yazici H., Fresko I., Hamuryudan V., Mat C., Melikoglu M., Ozyazgan Y., et al.
RHEUMADERM , cilt.455, ss.135-140, 1999 (SCI-Expanded, Scopus) identifier identifier identifier

99. Increased CD4+CD16+ and CD4+CD56+ T cell subsets in Behcet's disease

Eksioglu-Demiralp E., Direskeneli H., Ergun T., Fresko İ., Akoglu T.
Rheumatology International , cilt.19, ss.23-26, 1999 (SCI-Expanded, Scopus) identifier identifier identifier

100. Genetic anticipation in Behcet's syndrome

Fresko İ., Soy M., Hamuryudan V., Yurdakul S., Yavuz S., Tumer Z., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.57, sa.1, ss.45-48, 1998 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

101. Küçük damar vaskülitleri

FRESKO İ., MAT M. C., YURDAKUL S., TÜZÜNER N. N., TÜZÜN Y.
KLİNİK GELİŞİM , cilt.10, ss.199-205, 1997 (Hakemli Dergi)

102. Behçet's disease: a disease in search of its etiology.

ROUX H., FRESKO İ.
Revue du rhumatisme (English ed.) , cilt.62, sa.5, ss.339-342, 1995 (SCI-Expanded, Scopus) identifier identifier identifier

103. GENITAL ULCERATION IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS

FRESKO I., YAZICI H., ISCI H., YURDAKUL S.
LUPUS , cilt.2, sa.2, ss.135, 1993 (SCI-Expanded, Scopus) identifier identifier identifier

104. Effect of surgical cleaning of the skin on the pathergy phenomenon in Behget's syndrome

FRESKO İ., Yazicl H., Bayramiçli M., Yurdakul S., Mat C.
Annals of the Rheumatic Diseases , cilt.52, sa.8, ss.619-620, 1993 (SCI-Expanded, Scopus) identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 1

1. The disease presentation and outcome in children with Behcet's syndrome.

Seyahi E., Ozdogan H., Ugurlu S., Ozyazgan Y., Saip S., Mat C., et al.
69th Annual Scientific Meeting of the American-College-of-Rheumatology/40th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 12 - 17 Kasım 2005, cilt.52, (Özet Bildiri) identifier
Metrikler

Yayın

138

Yayın (WoS)

103

Yayın (Scopus)

97

Atıf (WoS)

2790

H-İndeks (WoS)

29

Atıf (Scopus)

4204

H-İndeks (Scopus)

34

Atıf (Scholar)

26

H-İndeks (Scholar)

2

Atıf (TrDizin)

1

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

1

Açık Erişim

18
BM Sürdürülebilir Kalkınma Amaçları